-
Mashup Score: 1STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock - 2 year(s) ago
September 20, 2022 — An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT Registry found that most patients with severe mitral regurgitation (MR) and cardiogenic shock (CS) who underwent mitral transcatheter edge-to-edge repair (TEER) in the United States achieved successful MR reduction, and that successful repair was associated with lower mortality and…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 8Transcatheter Edge-to-Edge Repair in Patients with Severe Mitral Regurgitation and Cardiogenic Shock: TVT Registry Analysis: - 2 year(s) ago
Abstract Background Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients with cardiogenic shock (CS) are limited. Objectives We investigated the characteristics and outcomes…
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: Trends in Structural Heart Procedural Imaging - a discussion with Rebecca Hahn - 2 year(s) ago
CVD recently conducted an interview with Rebecca T. Hahn, MD, Professor of Medicine at Columbia University Irving Medical Center, Chief Scientific Officer of the echo core lab at the Cardiovascular Research Foundation (CRF), and Director of Interventional Echocardiography at the Columbia Structural Heart and Valve Center. In it, she discusses some of the trends in the growing use of…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
A decade ago, when transcatheter aortic valve replacement (TAVR) was first cleared by the U.S. Food and Drug Administration (FDA), many expected TAVR would only be used in a small portion of patients, and surgeons had concerns about losing business. A decade on, the unexpected happened, and it turns out with TAVR, everyone is a winner, including the patient, interventional cardiologist, hospitals…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Maini was a pioneer in the heart team approach with the development of transcatheter aortic valve replacement (TAVR) a decade ago. This model included the interventional cardiologist, cardiac surgeon, interventional sonographer, cardiac imager or radiologist, nursing, patient navigator and other support staff so everyone is on the same page and has a say in selecting patients for transcatheter…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7VIDEO: The state of TAVR in 2022 - 2 year(s) ago
Michael Mack, MD, chairman of the cardiovascular service line, Baylor, Scott, White Health, cardiac surgeon, and a key pioneer in transcatheter aortic valve replacements (TAVR), explains the history of TAVR and where things are headed during the 2022 Transcatheter Valve Therapeutics (TVT) structural heart summit. TAVR in 2022 makes up about 84% of the aortic valve replacement procedure volume,…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2VIDEO: Advances in left atrial appendage occlusion technology - 2 year(s) ago
She discusses the two FDA cleared LAA occlusion (LAAO) devices, the Boston Scientific Watchman FLX and the Abbott Amulet, and new devices in development or already in trials. These include the CLAAS Conformal, Laminar, LAmbre and devices that may combine ablation with LAAO. Nair also discusses use of CT imaging to help size and preplan the LAA closure procedures and how transesophageal echo…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances - 2 year(s) ago
It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Several structural heart thought leaders, including Latib, shared this opinion, saying the tricupid is an easier valve to problem solve for, having the more complex anatomy and higher pressure environment of the left ventricle. The tricuspid valve is certainly no longer the…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: How to build a structural heart program - 2 year(s) ago
He explained the key elements required include: 1. Champion interventional cardiologists and cardiac surgeons who can work together as a team and share decision making for what is best for the patient. 2. Interventional imagers who can work as a key part of the team for pre-procedural evaluations and guide imaging during procedures. This is usually a dedicated interventional…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6TCT 2021 - 3 year(s) ago
Educational Grant SupportTCT is sponsored by the Cardiovascular Research Foundation (CRF) and partially funded through educational grants from commercial supporters.This program is made possible in part by the educational grant support of our industry colleagues who, like CRF, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF gratefully acknowledges…
Source: tct2021.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Curious about #TVT studies, plaque modification, #endovascular interventions, or #antiplatelet drug studies? Don't miss today's poster sessions at #TCT2021. https://t.co/RLWjT6RHxB @JoaoLCavalcante @brijmaini @NWeissmanMD @jgschwartzmd @IssamDMoussa1 @DrBillGray @SandeepNathanMD https://t.co/QsL5GXjF4U
-
@DAICeditor @crfheart An analysis from #STS/#ACC #TVT Registry found most patients with severe mitral regurgitation and #cardiogenicshock who underwent #mitral #transcatheter edge-to-edge repair (#TEER) in the US achieved successful MR reduction: https://t.co/tr97hlVFJc #TCT2022